Catalyst Biosciences, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Catalyst Biosciences, Inc. Website Screenshot

http://www.catalystbiosciences.com

Catalyst Biosciences, Inc. Company Intro

Catalyst is a clinical-stage biopharmaceutical company leveraging exceptional science to discover and develop essential medicines.

Industry

Healthcare

Catalyst Biosciences, Inc. Headquaters

611 Gateway Boulevard
South San Francisco,94080
United States


Catalyst Biosciences, Inc. Share price

27 Oct 2020 01:17 GMT

$5.37

-0.13 (-2.36 %)


Catalyst Biosciences, Inc. Market cap

$126.2 M


WMC RANKING

2020

Catalyst Biosciences, Inc. # 134

Biotechnology



Latest Catalyst Biosciences, Inc. News

News 26 Oct 2020

Tourette Syndrome Drug Market Growth Rate By Key Vendors ...

Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc, Reviva Pharmaceuticals Inc, Synchroneuron Inc, ...

News 26 Oct 2020

Tourette Syndrome Drug Market 2020: Key Growth Factors and Opportunity Analysis by 2027 | Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc

Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc, Reviva Pharmaceuticals Inc, Synchroneuron ...

News 26 Oct 2020

Adverum Biotechnologies (ADVM) Receives a Buy from ...

The company's shares closed last Monday at $11.78. ... focusing on stocks such as Axovant Gene Therapies, Taysha Gene Therapies, and Catalyst Biosciences.

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Catalyst Biosciences, Inc. 0.33 1.10 0.96 0 0 0 1.57
Alexion Pharmaceuticals, Inc. 100 13.26 100 18 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.09 25 0 0 98.33
3SBio Inc. 96.05 0 0 4 0 0 2.80
Incyte Corporation 40.27 14.26 7.21 100 0 0 92.34

Catalyst Biosciences, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Catalyst Biosciences, Inc. $18,024 $61,415 $-47,617 $121.346M 134
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.654B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $55.11B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.42B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.615B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Catalyst Biosciences, Inc. Social Followers vs Top 4 Industry Competitors



Catalyst Biosciences, Inc. Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries